Organon (OGN) Net Cash Flow (2020 - 2026)

Organon has reported Net Cash Flow for 7 years, with the latest figure at $19.0 million in Q2 2026.

• Net Cash Flow for Q2 2026 came in at $19.0 million, up 146.34% year-over-year; the trailing twelve-month figure through Jun 2026 was $554.0 million (up 360.09% YoY), and the FY2025 annual result was -$251.0 million, down 532.76% from the prior year.
• Net Cash Flow declined to $19.0 million in Q2 2026, from $573.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $573.0 million in Q1 2026 and troughed at -$266.0 million in Q1 2023.
• A 5-year average of $20.8 million and a median of $0.0 in 2024 frame the typical range for Net Cash Flow.
• The largest YoY upside for Net Cash Flow was 708.33% in 2025 against a maximum downside of 1025.0% in 2025.
• A 5-year view of Net Cash Flow shows it stood at $124.0 million in 2022, then surged by 92.74% to $239.0 million in 2023, then sank by 94.98% to $12.0 million in 2024, then tumbled by 1025.0% to -$111.0 million in 2025, then jumped by 117.12% to $19.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $19.0 million in Q2 2026, $573.0 million in Q1 2026, and -$111.0 million in Q4 2025.